Rutgers, The State University of New Jersey: Breast Neoplasms trials

The registry lists 28 Breast Neoplasms studies with Rutgers, The State University of New Jersey as lead sponsor. 5 are open to participants now and 12 have results posted.

Early Phase 1 1Phase 1 4Phase 2 12Phase 4 1No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-AdjustmentRecruitingNCT07158164Phase 4
• Rutgers University Study of the Genetics of Breast Cancer.RecruitingNCT06773897
• Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast CancerRecruitingNCT05736367Not applicable
• Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 TargetedRecruitingNCT05559164Phase 2
• Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary CareEnrolling by invitationNCT05400941Not applicable
• Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic InstabilityActive, not recruitingNCT03428802Phase 2Results posted
• Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) ProjectCompletedNCT03326713Not applicableResults posted
• Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic MastectomyCompletedNCT03061175Not applicableResults posted
• eHealth Weight Loss Program in African American Breast Cancer SurvivorsCompletedNCT02699983Not applicableResults posted
• Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After SurgeryCompletedNCT02526498Phase 2Results posted
• Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast CancerActive, not recruitingNCT02315196Phase 2Results posted
• Accelerated Radiation Therapy After Surgery in Treating Patients With Breast CancerCompletedNCT01417286Phase 2Results posted
• Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast CaTerminatedNCT00934895Phase 1/2Results posted
• Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast CancerCompletedNCT00634634Phase 1/2Results posted
• Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast CancerCompletedNCT00608972Phase 2Results posted
• Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast CancerTerminatedNCT00496366Phase 2Results posted
• Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast CancerTerminatedNCT00323063Phase 2Results posted
• Pilot Trial of Preop Partial Radiation in Breast Cancer PatientsSuspendedNCT07178665Phase 1
• Choices About Genetic Testing And Learning Your Risk With Smart TechnologyCompletedNCT06184867Not applicable
• CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early StageActive, not recruitingNCT05333874Early Phase 1
• Breast Cancer and Resistance Exercise ProgramTerminatedNCT04562233Not applicable
• Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal CancerCompletedNCT03233555Not applicable
• Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersCompletedNCT03112668Not applicable
• Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic SyndromeTerminatedNCT00946283Not applicable
• Radiation Therapy in Treating Women With Early Stage Breast CancerActive, not recruitingNCT00909909Phase 2
• Studying Tumor Tissue Samples From Patients With Early-Stage Breast CancerWithdrawnNCT00899639
• Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy CompanionsTerminatedNCT00891969
• Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerStatus unknownNCT00553683Phase 1/2